Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Salvatore Carbone

Showing results (131-140 of 134) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 134 results.
Diabetes/Metabolism Research and Reviews|May 17, 2020
The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The CANA-HF studySalvatore Carbone, Hayley E Billingsley, Justin M Canada, et al.
Clinical Cardiology|July 24, 2018
Rationale and design of the Virginia Commonwealth University-Anakinra Remodeling Trial-3 (VCU-ART3): A randomized, placebo-controlled, double-blinded, multicenter studyBenjamin W Van Tassell, Michael J Lipinski, Darryn Appleton, et al.
Journal of the American Heart Association|March 4, 2020
Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST-Segment-Elevation Myocardial InfarctionAntonio Abbate, Cory R Trankle, Leo F Buckley, et al.
Circulation. Heart Failure|December 23, 2025
Resolution of Systemic Inflammation in Patients With Recently Decompensated Heart Failure With Reduced Ejection Fraction With and Without Interleukin-1 Blockade by AnakinraBenjamin W Van Tassell, Michele Golino, Justin M Canada, et al.
Pageof 14

Showing results (131-140 of 134) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 134 results.
Diabetes/Metabolism Research and Reviews|May 17, 2020
The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The CANA-HF studySalvatore Carbone, Hayley E Billingsley, Justin M Canada, et al.
Clinical Cardiology|July 24, 2018
Rationale and design of the Virginia Commonwealth University-Anakinra Remodeling Trial-3 (VCU-ART3): A randomized, placebo-controlled, double-blinded, multicenter studyBenjamin W Van Tassell, Michael J Lipinski, Darryn Appleton, et al.
Journal of the American Heart Association|March 4, 2020
Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST-Segment-Elevation Myocardial InfarctionAntonio Abbate, Cory R Trankle, Leo F Buckley, et al.
Circulation. Heart Failure|December 23, 2025
Resolution of Systemic Inflammation in Patients With Recently Decompensated Heart Failure With Reduced Ejection Fraction With and Without Interleukin-1 Blockade by AnakinraBenjamin W Van Tassell, Michele Golino, Justin M Canada, et al.
Pageof 14